Investigational Drugs
The Investigational Drugs API helps you leverage competitive intelligence to inform your strategic decisions across each drug development stage and to act before your competitors. Get the full picture of the competitive landscape in your chosen therapy area with accurate and timely global information.
Investigational Drugs API can help you to
- Find new drug development opportunities and evaluate potential before anyone else
- Research competitor pipelines
- Identify market gaps early
- Look for potential partners
- Assess comparable deals
- Review a company's strategic portfolio
- Closely monitor your competitors and seize opportunities to stay ahead
- Display competitive intelligence information (drugs, competitors, phases, technologies, indications, and actions) the way you want it in an easy-to-access format tailored to your specific need
Content
- Drug reports provide details on the current and historical development status of a drug. These reports include information from the companies involved in the drug's discovery and development to chemical structure, details, and indications in discovery and development among other data
- Reported and forecasted sales figures for specific years are available for all companies involved in the marketing of a specific drug
- SWOT coverage of late-stage clinical and launched drugs, providing an analysis of a drug's performance against its competitors
- Company reports include details on company areas of research, their financial state, and drug pipeline. They also include reported sales and consensus forecasts on company drugs and listings of significant partnerships and drug licensing deals
- Deal reports include a summary and breakdown of financial information (where available), milestones, timelines, and relevant drugs and patents associated with each deal
- Dynamic executive summaries on the current status of and future trends in drug therapy for specific diseases
Entities diagram (Colour coding – green: main entities | purple: supporting entities)
Search results, retrieve and export drug (detailed monographs and sales forecasts), deal and company (organizations involved in drug discovery & development) records; search and retrieve disease briefing records; search and browse different controlled vocabularies (indication, action, technology); retrieve a matrix of drugs and their development events grouped by company / action / indication.
This Pipeline Pilot protocol finds immuno-oncology clinical trials for the chosen indication. Each trial charts adverse events and trial report and a series of graphs shows adverse events and drugs across the all the matching trials.
Note: 1596 in the query corresponds to Immunomodulator.
APIs involved in this demo: Clinical, Investigational Drugs APIs.
This demo returns the top 10 indications, HQ countries, top 10 actions, number of drugs & deals and number of patents. It also allow access to the detailed company record.
API involved in this demo: Investigational Drugs API.
Search for deals and provide an overview of the top 10 indications, deal status and types, principal and partner companies. It also allow access to the detailed deals record.
API involved in this demo: Investigational Drugs API.
This demo returns the top 10 indications, actions, companies, technologies and the number of drugs categorized by highest development phase. It also allow access to the detailed drug record.
API involved in this demo: Investigational Drugs API.
For a given indication, retrieve drugs from Investigational Drugs API. For a the selected drugs, find trial results from the Clinical API, drill down to trial records that may be combined with data from Regulatory API.
APIs involved in this demo: Investigational Drugs, Clinical and Regulatory APIs.
Indication-centric infographic.
APIs involved in this demo: Investigational Drugs API to access drugs, companies and deals, Clinical API to access trials, conferences, press release and literatures (articles), Ontologies API for the indications and indication synonyms, Patents and Targets APIs.